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The life expectancy of persons cycling through the prison system is unknown. The authors sought to determine
the 15.5-year survival of 23,510 persons imprisoned in the state of Georgia on June 30, 1991. After linking prison
and mortality records, they calculated standardized mortality ratios (SMRs). The cohort experienced 2,650 deaths
during follow-up, which were 799 more than expected (SMR ¼ 1.43, 95% conﬁdence interval (CI): 1.38, 1.49).
Mortality during incarceration was low (SMR ¼ 0.85, 95% CI: 0.77, 0.94), while postrelease mortality was high
(SMR ¼ 1.54, 95% CI: 1.48, 1.61). SMRs varied by race, with black men exhibiting lower relative mortality than
white men. Black men were the only demographic subgroup to experience signiﬁcantly lower mortality while
incarcerated (SMR ¼ 0.66, 95% CI: 0.58, 0.76), while white men experienced elevated mortality while incarcerated
(SMR ¼ 1.28, 95% CI: 1.10, 1.48). Four causes of death (homicide, transportation, accidental poisoning, and
suicide) accounted for 74% of the decreased mortality during incarceration, while 6 causes (human immunodeﬁ-
ciency virus infection, cancer, cirrhosis, homicide, transportation, and accidental poisoning) accounted for 62% of
the excess mortality following release. Adjustment for compassionate releases eliminated the protective effect of
incarceration on mortality. These results suggest that the low mortality inside prisons can be explained by the rarity
of deaths unlikely to occur in the context of incarceration and compassionate releases of moribund patients.
cause of death; health status disparities; hepatitis C; mortality; prisons; prisoners; survival analysis
Abbreviations: CI, conﬁdence interval; GDC, Georgia Department of Corrections; HIV, human immunodeﬁciency virus; SMR,
standardized mortality ratio.
Editor’s note: An invited commentary on this article ap-
pears on page 488.
As a consequence of political pressure to increase pun-
ishment for crime, the United States leads the world in rates
of incarceration (1). The length of time that a particular
prisoner serves behind bars may depend on both structural
factors (the laws of the state, the conduct of the jury and
judge, underlying racism, etc.) and individual factors (the
particular crime committed; educational level, which in turn
affects the ability to afford skilled legal counsel) (2). A
multitude of causes, including high rates of substance abuse,
engagement in risky sexual behaviors, intermittent home-
lessness, and poor access to mental health care, can explain
why the 10.7 million persons who spent at least a portion of
the year 2006 in a US prison or jail (3) are believed to have
poorer health on average than the general population (4, 5).
For example, the prevalence of human immunodeﬁciency
virus (HIV) infection among US prisoners is 3.8 times that
for US adults as a whole (6, 7). Many predictors of criminal
activity are also predictors of poor health outcomes. Numer-
ous studies have demonstrated that the period immediately
following release, especially the ﬁrst month, is associated
with high mortality (8–20). Causes of deaths occurring more
frequently than expected among releasees include 6 condi-
tions of particular interest in correctional populations: HIV
infection, homicide, transportation injuries, accidental
479 Am J Epidemiol 2011;173:479–487poisoning (including drug overdose), suicide, and liver dis-
ease (8, 21). The long-term health outcomes of persons
cycling into and out of prisons are generally unknown; cur-
rent beliefs are inferred from cross-sectional studies carried
out in current prisoners and short-term follow-up studies of
releasee cohorts.
Sex and race are important predictors of mortality in re-
leasees. For example, in Washington State, women ex-
hibited signiﬁcantly higher adjusted relative rates of death
than men after release from prison (8). The adjusted relative
rate also varied by race, with blacks having the lowest
adjusted relative rate (8), perhaps due to white prisoners’
having a greater disparity in underlying health compared
with their nonincarcerated racial counterparts (22). In
a North Carolina study of male releasees, white ex-prisoners
were shown to have twice the mortality of other white men,
while black ex-prisoners were shown to have the same
mortality as other black residents (21).
Based on the relatively poor health of incarcerated pop-
ulations and the high mortality rates seen after release, one
might predict that inmates would also suffer from high mor-
tality while incarcerated. A recent Bureau of Justice Statis-
tics report, however, showed that while incarcerated,
inmates aged 15–64 years experience 19% lower mortality
than comparably aged controls in the general population;
among blacks, mortality for prisoners is 43% lower than
age-adjusted mortality for the general black population
(23). A mortality study of French prisoners (1977–1983)
similarly found lower mortality among prisoners while in-
carcerated, with a standardized mortality ratio (SMR) of
0.92 after adjustment for age and sex (24). A 20-year mor-
tality study among persons under age 60 years in English
and Welsh prisons demonstrated an SMR of 0.70 (25). Sev-
eral factors could explain the lower prison mortality relative
to the general population: access to health care that many
persons lack on the outside; a controlled environment, with
fewer hazards and a more regular sleep schedule and diet;
compassionate release of moribund inmates just prior to
death; and selection of already-healthy persons based on
their ability to commit crime.
The last of these hypotheses, that persons who are incar-
cerated enter prison healthier than the general population,
has been proposed previously (25). It is analogous to a con-
cept encountered in the ﬁeld of occupational health, the
‘‘healthy worker effect.’’ This term reﬂects the fact that
a person must be relatively healthy for employment in the
workforce and must remain healthy to remain employed
(26). Consequently, both morbidity and mortality rates
within the workforce trail those in the general population
(27). A similar phenomenon—a person must be healthy in
order to commit certain crimes—may operate in inmate co-
horts. This suggests the possibility of a ‘‘healthy prisoner
effect.’’
While prior research has observed lower mortality while
inmates are inside prison and higher mortality immediately
followingrelease,researchintotherelativestrengthofthetwo
effects is lacking. Prompt treatment of urgent health needs
in prisons is both a moral and a legal imperative (28, 29),
but some diseases, such as hepatitis C, can take over 30 years
to fully manifest into life-threatening conditions (30). If life
expectancy is long, prison health-care providers should be
more aggressive in addressing slow-moving health threats;
the long-term health needs of prisoners may be equally as
important as short-term risk reduction.
Much of the existing literature has focused on mortality
either in releasee cohorts or in continually imprisoned co-
horts. Except for 2 long-term follow up studies of juvenile
delinquents (31, 32) and a small (n ¼ 4,615) study in the
Netherlands (the Criminal Careers and Life Course Study)
(33), we are unaware of any long-term longitudinal studies,
even though the life experience of the majority of offenders
involves cycling into and out ofinstitutions. Herewe present
results of a studydesigned to explorewhether the potentially
protective effects of incarceration persist over time and
whether the low mortality inside of prison offsets the higher
risk of mortality after release. Figure 1 displays some pos-
sible incarceration histories of subjects.
MATERIALS AND METHODS
Georgia prison cohort
The study cohort consisted of all persons incarcerated in
a Georgia state prison on June 30, 1991. Retrospective fol-
low-up of the cohort for mortality was performed through
December 31, 2006. Data on this cohort, including lifetime
incarceration history, came from the Planning and Strategic
Management Section of the Georgia Department of Correc-
tions (GDC).
All cohort members whose mortality status was unknown
as of December 31, 2006, according to GDC records were
matched with death information from the Georgia Death
Registry, which maintains death certiﬁcates for deceased
persons in Georgia. Next, names of persons not matched to
the Georgia Death Registry were submitted to the National
Death Index to obtain mortality records for persons who died
outside of Georgia. In both stages, inmates were matched on
the basis of name, Social Security number, age, home ad-
dress, and known aliases. For both the Georgia Death Reg-
istry and the National Death Index, we accepted as true
matches those records which the registries classiﬁed as true.
Deaths were classiﬁed as occurring either inside or out-
side of prison on the basis of GDC records. We categorized
prisoners by educational level (attainment of a high school
diploma before or during the study period vs. no attainment)
as a proxy for socioeconomic status. Total, nonincarcerated,
and incarcerated person-time for each age, sex, race, and
educational group in the inmate cohort were calculated for
each year of the study. Nonincarcerated person-time in-
cluded all time (both between incarcerations and following
the ﬁnal incarceration) cohort members had spent outside of
the Georgia prison system during the study period. Mean
ages weighted by person-time during nonincarcerated and
incarcerated periods were calculated. SMRs were calculated
by comparison with the age-, sex-, race-, and calendar-year-
adjusted Georgia population rates. SMRs were also calcu-
lated by educational leveland for cross-tabulated subgroups.
All SMRs were calculated using Life Table Analysis
System software (LTAS.NET) from the National Institute
for Occupational Safety and Health (8, 21).
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discrete time segments of 0–<1 month, 1–<6 months, and
6–12 months. The analysis of time since release included all
releases (i.e., a person released thrice would contribute 3
months to the 0- to <1-month SMR, assuming survival after
the third release).
We adjusted mortality rates to investigate the potential
effect of a program of releasing moribund inmates just prior
to death. A former Georgia prison medical director
(Dr. J. Paris, DeKalb County (Georgia) Board of Health,
personal communication, 2009) estimated the range of an-
nual numbers of compassionate releases. We performed
a sensitivity analysis of the effect of this program using
the lower and upper bounds of the range of annual numbers
of compassionate releases.
To assess the causes of lower-than-expected mortality
during incarceration and excess mortality after release from
prison, we calculated cause-speciﬁc SMRs for select causes
of death that had signiﬁcantly lower- or higher-than-
expected frequencies among releasees in previous US stud-
ies. We then calculated the proportion of unexpected deaths
due to these causes, deﬁned as the sum of the excess deaths
from each cause (observed minus expected) divided by the
total number of excess deaths.
The Emory University Institutional Review Board ap-
proved this study. All data management and analysis was
performed using the Statistical Analysis System, version 9.2
(SAS Institute Inc., Cary, North Carolina). Data were
stripped of identifying information prior to analysis.
RESULTS
In this cohort of 23,510 Georgia inmates incarcerated on
June 30, 1991, 20,860 persons were alive and 2,650 were
reported deceased as of December 31, 2006. Table 1 shows
selected demographic characteristics. The cohort was 95%
male and two-thirds black, a distribution consistent with
current Georgia prison demographics. The 973 persons ever
testing HIV-positive included 92 persons who seroconverted
Figure 1. Several possible incarceration histories in a study of incarceration and health status, with the sole inclusion criterion being incarceration
at the start of the study, Georgia, 1991–2006.
Table 1. Selected Demographic Characteristics of a Prisoner
Cohort, Georgia, 1991–2006
Characteristic No. %
Sex-race group
Black men 14,714 63
Nonblack men 7,494 32
Black women 829 4
Nonblack women 473 2
No prior incarcerations at study start 12,090 51
HIV status during observation period
Ever HIV-positive 973 4
Always HIV-negative 21,839 93
Indeterminate result or missing data 698 3
HIV seroconversion during study period 92
No. of releases during study period
0 2,316 10
1 15,407 66
2 3,129 13
3 1,599 7
 4 1,059 5
Mean age (SD) on June 30, 1991, years 24 (9)
Abbreviations: HIV, human immunodeﬁciency virus; SD, standard
deviation.
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years of observation. All National Death Index matches
were accepted as true matches; we identiﬁed no false pos-
itives (i.e., a situation where we could demonstrate that
a person with a National Death Index match was identiﬁed
as still residing in prison past the putative date of death).
Over the study period, 20,788 (90%) of the 23,104 cohort
members who did not die in prison were released at least
once. Women spent a signiﬁcantly lower amount of their
total person-time in prison than men (16% and 24%, respec-
tively; 2-tailed t test: P < 0.001). There were no racial
differences in the proportion of person-time spent incarcer-
ated (data not shown). Weighted by person-time, the mean
age during incarceration was 30 years, while during non-
incarceration it was 35 years.
Figure 2 displays the observed and predicted numbers of
persons alive in each year of follow-up. Observed mortality
was consistently higher than expected, as illustrated by the
continually diverging survival curves. We calculated accel-
erated mortality as the difference between a given date and
the date on which the number of deaths predicted to have
occurred did in fact occur, divided by the total follow-up
time to that point—in other words, the percentage of time up
to a given point by which the expected mortality was accel-
erated. In the years 1995, 2000, and 2005, observed deaths
were accelerated by 19%, 27%, and 25%, respectively. The
total mortality expected to occur over the 15.5 years of
follow-up was reached in only 11.6 years. Overall, the
2,650 observed deaths represented a mortality rate 43%
higher than expected (see Table 2 and Figure 2). Stratiﬁed
by race and sex, black men in the cohort experienced the
lowest mortality relative to their age-, race-, and sex-
matched peers in the community (Table 3; SMR ¼ 1.18,
95% conﬁdence interval (CI): 1.12, 1.24). Because this
group dominated the cohort, overall mortality was driven
by their experience. Nonblack males had mortality nearly
double that of their Georgia counterparts, while both black
and nonblack females died at more than twice the expected
rate(SMR ¼ 2.13 and SMR ¼ 2.92, respectively; see Table 3).
SMRs did not vary by educational level, the proxy for socio-
economic status.
Mortality by incarceration status
Therewere 406 deaths that occurred while cohort mem-
bers were incarcerated, yielding an in-prison SMR of 0.85
(95% CI: 0.77, 0.94). In prison, black men experienced
the lowest relative mortality and were the only sex-race
group with an SMR signiﬁcantly less than 1 (SMR ¼ 0.66,
95% CI: 0.58, 0.76; Table 3). Conversely, nonblack men
had a 28% higher-than-expected risk of mortality while
incarcerated, based on their referent Georgia population
(SMR ¼ 1.28, 95% CI: 1.10, 1.48). The small number of
deaths occurring in prison among women in this cohort
resulted in wide conﬁdence intervals overlapping the null
value.
Figure 2. Observed and expected mortality in a prisoner cohort, Georgia, 1991–2006.
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elevated relative to Georgia counterparts (SMR ¼ 1.54,
95% CI: 1.48, 1.61). Similar to results during incarceration,
black men had the lowest relative mortality (SMR ¼ 1.29,
95% CI: 1.22, 1.36) and nonblack women had the highest
relative mortality(SMR¼ 3.56, 95% CI: 2.59,4.78;Table3).
This pattern is consistent with the differential incarceration
rates between these populations in general society, with black
males being incarcerated at signiﬁcantly higher rates than
other demographic subgroups.
We calculated SMRs for the 0–<1m o n t h ,1 – <6m o n t h ,
and 6–12 month periods following release, with all releases
considered. We observed a heightened SMR during the
month following release (n ¼ 19 deaths; SMR ¼ 1.90,
95% CI: 1.18, 2.91), but the wide conﬁdence intervals
overlapped the overall postrelease SMR of 1.54, making
comparisons difﬁcult. We did not observe the extremely high
mortality immediately postrelease reported in previous stud-
ies (8, 11). SMRs during the periods 1–<6 months after re-
lease and 6–12 months after release were 1.67 (95% CI: 1.36,
2.03) and 1.64 (95% CI: 1.33, 1.99), respectively; these
SMRs were not signiﬁcantly different from the overall post-
release SMR of 1.54, showing that the early spike in post-
release mortality in this cohort steadily regressed towards the
level of the overall, still-heightened postrelease mortality.
Stratiﬁcation by age
Mortality patterns differed by age, with former prisoners
aged 65 years or more exhibiting a lower-than-expected
Table 3. Numbers of Expected and Observed Deaths and Standardized Mortality Ratios in a Prisoner Cohort, by Sex-Race Group, Georgia,
1991–2006
a
Sex-Race
Group
In Prison Out of Prison Overall
Obs Exp SMR 95% CI Obs Exp SMR 95% CI Obs Exp SMR 95% CI
Men
Black 215 324 0.66 0.58, 0.76 1,309 1,013 1.29 1.22, 1.36 1,524 1,292 1.18 1.12, 1.24
Nonblack 182 142 1.28 1.10, 1.48 812 392 2.07 1.93, 2.22 994 503 1.98 1.86, 2.10
Women
Black 6 5 1.21 0.44, 2.63 79 36 2.22 1.76, 2.76 85 40 2.13 1.70, 2.63
Nonblack 3 4 0.79 0.16, 2.31 44 12 3.56 2.59, 4.78 47 16 2.92 2.14, 3.88
Abbreviations: CI, conﬁdence interval; Exp, expected no. of deaths; Obs, observed no. of deaths; SMR, standardized mortality ratio.
a Numbers of expected deaths may not add up to total numbers because of rounding.
Table 2. Numbers of Expected and Observed Deaths and Standardized Mortality Ratios in a Prisoner Cohort and Its Demographic Subgroups,
Georgia, 1991–2006
a
In Prison Out of Prison Overall
Obs Exp SMR 95% CI Obs Exp SMR 95% CI Obs Exp SMR 95% CI
Total 406 475 0.85 0.77, 0.94 2,244 1,453 1.54 1.48, 1.61 2,650 1,851 1.43 1.38, 1.49
Sex
Male 397 466 0.85 0.77, 0.94 2,121 1,405 1.51 1.45, 1.58 1,795 2,518 1.40 1.35, 1.46
Female 9 9 1.03 0.47, 1.95 123 48 2.56 2.13, 3.06 132 56 2.36 1.97, 2.79
Race
Black 221 329 0.67 0.59, 0.77 1,388 1,049 1.32 1.25, 1.40 1,609 1,332 1.21 1.15, 1.27
Nonblack 185 146 1.27 1.09, 1.47 856 404 2.12 1.98, 2.26 1,041 519 2.01 1.89, 2.13
Age group, years
<65 373 446 0.84 0.75, 0.93 2,183 1,357 1.61 1.54, 1.68 2,556 1,758 1.45 1.40, 1.51
 65 33 29 1.13 0.78, 1.58 61 96 0.63 0.48, 0.81 94 93 1.01 0.82, 1.24
Educational level
Less than high
school
diploma
234 278 0.84 0.74, 0.96 1,310 878 1.49 1.41, 1.57 1,544 1,102 1.40 1.33, 1.47
High school
diploma
or more
149 178 0.84 0.71, 0.98 821 511 1.61 1.50, 1.72 970 668 1.45 1.36, 1.55
Abbreviations: CI, conﬁdence interval; Exp, expected no. of deaths; Obs, observed no. of deaths; SMR, standardized mortality ratio.
a Because of rounding and missing values, numbers of expected deaths may not add up to totals.
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95% CI: 0.48, 0.81). Similarly to aggregate results, incar-
cerated inmates under age 65 years were slightly protected
against mortality (SMR ¼ 0.84, 95% CI: 0.75, 0.93), while
small numbers precluded conclusions about incarcerated in-
mates aged 65 years or more.
Effects of compassionate release and unlikely causes
of death on mortality during incarceration
To investigate the signiﬁcantly depressed mortality levels
observed during incarceration, a ﬁnding conﬁrmed by prior
studies, we adjusted in-prison mortality for the effect of the
compassionate release program. A former GDC medical
director estimated that 10–22 compassionate releases oc-
curred annually in Georgia during our study period
(Dr. J. Paris, DeKalb County (Georgia) Board of Health,
personal communication, 2009). Consequently, we perfor-
med a sensitivity analysis to determine the effect of com-
passionate releases. We recalculated the in-prison SMR
adding either 150 deaths or 330 deaths to the observed
counts and obtained upper and lower estimates, each with
95% conﬁdence intervals. Because there were only 69 fewer
deaths than expected, compassionate releases can account
for any depressed mortality during incarceration observed
during our study period. Adjusted SMRs for in-prison mor-
tality ranged from 1.17 (95% CI: 1.08, 1.27) to 1.55 (95%
CI: 1.44, 1.66). However, even fewer than 150 compassion-
ate releases could be attributed to the cohort if some of the
releases during the observation period came from persons
admitted to Georgia prisons after 1991. It is theoretically
possible, though unlikely, that all compassionate releases
during the study period could have been among persons
admitted after the start of the observation period, in which
case the compassionate release program would explain none
of the depressed mortality.
As a potential secondary explanation for the depressed
mortality during incarceration, we obtained cause-speciﬁc
SMRs for select deaths that are unlikely to occur in prison
(Table 4). As expected, no deaths from transportation injuries
occurred during incarceration, and this alone accounted
for 42% of the lower-than-expected mortality. Lower rates
of homicide, accidental poisoning (drug overdose), and
suicide accounted for 16%, 7%, and 9% of the lower-than-
expected mortality, respectively. Had these 4 events occurred
at rates predicted by the referent population, 74% of the de-
pressed mortality would have been removed. Such an analy-
sis does not remove the fact that mortality was signiﬁcantly
lower than expected during incarceration, but it suggests that
simple factors related to immobilization and heightened sur-
veillance in the prison environment may explain the apparent
protective effect.
Mortality due to HIVinfection and hepatitis was of a pri-
ori interest. Levels of both HIVinfection and cirrhosis were
elevated relative to the referent population. Over the entire
study period, 387 persons died from HIV-related causes
(SMR ¼ 1.84, 95% CI: 1.66, 2.04) and 64 persons died from
cirrhosis and other liver diseases (SMR ¼ 1.87, 95% CI:
1.44, 2.39). HIV mortality varied over the course of the
study period, with relative mortality peaking during the
years 1995–1999 (SMR ¼ 2.00, 95% CI: 1.71, 2.34). From
2000 to 2006, the SMR was 1.72 (95% CI: 1.42, 2.06), in-
dicating a potential drop in HIV-related mortality relative to
the general population, but HIV mortality was still signiﬁ-
cantly elevated, as expected.
Excess mortality following release
Six causes of death accounted for 62% of the excess
mortality in former prisoners, with HIV and homicide ac-
counting for 20% and 18%, respectively (Table 5). Cancer
and heart disease were the 2 leading causes of death, but
cancer accounted for only 7% of the excess mortality, while
heart disease did not occur signiﬁcantly more than expected
(data not shown). Transportation injuries, accidental poison-
ings, and cirrhosis of the liver accounted for 17% of the
excess mortality.
DISCUSSION
We observed overall heightened mortality in our cohort
over 15 years of follow-up relative to the general Georgia
population. This is not unexpected given that less than one-
quarter of person-time was spent incarcerated, where any
potentially protective effect may occur. We observed
Table 4. Standardized Mortality Ratios for Leading Causes of Low Mortality During
Incarceration, Georgia, 1991–2006
Cause of
Death
No. of Deaths Standardized
Mortality Ratio
95% Conﬁdence
Interval
% Unexpected
Mortality
a
Observed Expected
Accidental
poisoning
1 6 0.16 0.00, 0.89 –7
Homicide 20 31 0.65 0.40, 1.00 –16
Suicide 11 17 0.65 0.33, 1.17 –9
Transportation
injuries
0 29 N/A N/A –42
Total 32 83 0.39 0.27, 0.54 –74
Abbreviation: N/A, not applicable.
a There were 69 fewer deaths than expected. The percentage of unexpected mortality was
calculated as ([observed   expected]/69) 3 100.
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only for black men after stratiﬁcation by sex and race.
The distribution of person-time was such that this protective
effect was overwhelmed by the heightened mortality
postrelease.
We do not believe a ‘‘healthy prisoner effect’’ exists. The
decreased mortality during incarceration in our cohort can
be explained by 2 factors: compassionate release and causes
of death for which prisoners are not at risk while incarcer-
ated. We calculate that compassionate release practices
alone can account for the depressed mortality in prisons;
the magnitude of the effect of the compassionate release
program speciﬁcally on the Georgia cohort incarcerated in
1991 cannot be known with certainty, because we do not
know what percentage of the entire prison population re-
leased under the program during the observation period
came from the study cohort. In addition, because we had
no individual data on compassionate releases taking place
during the study period, we could not apportion the releases
by age, sex, or race, precluding conclusions about the effect
on speciﬁc demographic subgroups. In addition to compas-
sionate releases, we found that much of the low mortality
inside prisons can be accounted for by the nature of the
prison environment. The lack of transportation injuries
alone accounted for over 40% of the deviation from ex-
pected mortality. As such, the apparently low mortality
may be an artifact of these institutional protections, rather
than any ‘‘healthy’’ effect of incarceration.
The lowest adjusted mortality rate was observed in black
men during incarceration, in accordance with recent studies
carried out in both Washington State and North Carolina (8,
34). Contrasting 2 external comparisons, blacks versus
whites, has limitations because referent populations differ.
One possible explanation for the lower SMR observed in
black men is the high prevalence of former incarceration in
this group in society generally. A Bureau of Justice Statis-
tics report estimated that, in 2001, 16.6% of black adult men
had spent time in state or federal prison during their life,
while only 2.6% of white adult men had ever been impris-
oned (35). This effective misclassiﬁcation of the reference
group results in SMRs that are standardized to persons who
have previously been incarcerated, diluting the effect of in-
carceration. Moreover, the large difference between black
and white incarceration rates in the general population
makes comparisons using SMRs problematic, because the
misclassiﬁcation occurs differentially. Another effect of the
high incarceration rate among blacks in the general popu-
lation is that blacks who are incarcerated will be a more
representative sample of the general population than whites,
who are incarcerated at a much lower rate, and can therefore
represent a more extreme subsample of the reference
population.
Limitations
Our study cohort may no longer be representative of the
Georgia prison population. Since 1991, when this cohort
was deﬁned, the number of prisoners in both Georgia and
the United States as a whole has more than doubled, and
between 1992 and 2006, HIV prevalence in state prisons fell
from 2.7% to 1.8% (7, 36). Moreover, the Georgia prison
population is not necessarily representative of the US pop-
ulation as a whole. Heroin injection has become rare in
Georgia (37), which may explain why overdose death was
less common than in the recent study of releasees in the state
of Washington (8). Premature mortality is a crude proxy for
health, and our study provides little information concerning
the quality of life of former prisoners.
Strengths
Our ﬁndings illustrate that the common assertion that in-
mates are ‘‘10 or more years older’’ in health terms than
similarly aged free persons (38, 39) is an oversimpliﬁcation
of the health of prisoners. Rather, the ‘‘shift’’ in mortality or
morbidity is dependent on the age of the prisoner and the
amount of time considered for follow-up. If our results were
extrapolated, our cohort would have to be followed for 40
years before a 10-year difference in total mortality was
observed (25% accelerated mortality).
Table 5. Standardized Mortality Ratios for Leading Causes of Excess Mortality Following
Release From Prison, Georgia, 1991–2006
Cause of Death
No. of Deaths Standardized
Mortality Ratio
95%
Conﬁdence
Interval
% Excess
Mortality
a
Observed Expected
Accidental poisoning 80 23 3.48 2.76, 4.33 7
Cancer 326 268 1.22 1.09, 1.35 7
Cirrhosis and other
liver diseases
52 26 1.99 1.48, 2.60 3
Homicide 215 76 2.84 2.47, 3.24 18
Human
immunodeﬁciency
virus
313 156 2.00 1.78, 2.23 20
Transportation injuries 140 86 1.63 1.37, 1.92 7
Total 1,126 635 1.77 1.67, 1.88 62
a There were 791 excess deaths following release. The percentage of excess mortality was
calculated as ([observed   expected]/791) 3 100.
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While mortality is extremely high immediately after
prison release for some discharge cohorts, our study popu-
lation of persons discharged over a period of years persis-
tently demonstrated moderately heightened mortality.
Health-care planning for a population of prisoners should
not ignore long-term health needs. Interventions such as
treatment for hepatitis C could result in an appreciable num-
ber of years of life gained for persons who pass through
a correctional institution (30). A national expert on the cost
of correctional health care estimated that the United States
currently spends $9.9 billion annually on medical services
in prisons (Dr. J. Moore, independent nurse consultant, per-
sonal communication, 2010). State ofﬁcials have a ﬁduciary
duty to use evidence when planning how to spend prison
health-care dollars, but data have often been insufﬁcient.
When planning for the health of prisoners, more emphasis
should be placed on the individual life course in its entirety.
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